Vergis, Pablita B.
HRN: 11-72-62 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/06/2023
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
12/06/2023
12/12/2023
IVT
1.5gms
Q8
Dm Foot Grade 3
Waiting Final Action
Indication: Empiric Type of Infection: Bone & JointSkin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes